Correction: Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-08-01
|
Series: | Ophthalmology and Therapy |
Online Access: | https://doi.org/10.1007/s40123-023-00788-9 |